BioCorRx (BICX) Shares Outstanding (2010 - 2026)

BioCorRx has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $6.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 60.35% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 60.35% YoY) and the FY2025 annual result came in at $7.0 million, down 32.7% from the prior year.
• Shares Outstanding (Entity) slipped to $6.7 million in Q1 2026 per BICX's latest filing, from $7.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $20.2 million in Q3 2025 and troughed at $6.7 million in Q1 2026.
• A 5-year average of $10.1 million and a median of $8.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 89.93% in 2025, then sank 60.35% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $7.7 million in 2022, then increased by 12.38% to $8.7 million in 2023, then advanced by 20.64% to $10.5 million in 2024, then sank by 32.7% to $7.0 million in 2025, then slipped by 4.86% to $6.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $6.7 million, $7.0 million, and $20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.